Stocks · Health care · Biological Products, (No Diagnostic Substances)

EXELIXIS, INC.

EXEL Clue Score84

United States Fiscal year ends January CIK 0000939767 Results filed 29 Oct 2026

Add to watchlist

What the insiders did Net selling

Bought (12 mo)

$1.19M

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$42.24M

$2.54M on a plan · $12.75M straight out of an exercise

Sold at will

$26.95M

16 of 32 sales

Net

−$41.06M

−$25.76M against sales at will